Artman Lutheran Home | |
250 North Bethlehem Pike, Ambler, Pennsylvania 19002 | |
(215) 643-6333 | |
Name | Artman Lutheran Home |
---|---|
Location | 250 North Bethlehem Pike, Ambler, Pennsylvania |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 61 |
Occupancy Rate | 78.69% |
Medicare ID (CCN) | 395922 |
Legal Business Name | Artman Lutheran Home |
Ownership Type | Non Profit - Corporation |
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Using a combination of genetic linkage, microarray gene expression and genetic association studies, a group of Brigham and Women's Hospital/ Harvard Medical School researchers have identified a serine protease inhibitor clade E, member 2, or SERPINE2, "as a novel candidate susceptibility gene for COPD," according to Sorachai Srisuma
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced the Canadian launch of ABLAVAR (gadofosveset trisodium injection), a unique, injectable magnetic resonance angiography (MRA) blood pool imaging agent.
Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced that it has entered into an exclusive worldwide license agreement for a novel source of primary human cells that secrete a factor capable of inhibiting tumor cell growth and causing tumor cell death.
Twenty percent of adults who have tonsillectomies will have a complication, which is significantly higher than previously shown, according to a team of researchers. The team also found that these complications substantially increase health care expenditures.
› Verified 6 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 20.83 | 14.46 |
Percentage of long-stay residents who lose too much weight | 4.2 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 84.31 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.14 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 4.55 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 2.99 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 7.35 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 89.71 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 16.42 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 67.27 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.97 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 32.09 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 15.45 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 12.5 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.33 | 95.98 |
Percentage of short-stay residents who made improvements in function | 56.16 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 65.82 | 82.93 |
News Archive
Using a combination of genetic linkage, microarray gene expression and genetic association studies, a group of Brigham and Women's Hospital/ Harvard Medical School researchers have identified a serine protease inhibitor clade E, member 2, or SERPINE2, "as a novel candidate susceptibility gene for COPD," according to Sorachai Srisuma
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced the Canadian launch of ABLAVAR (gadofosveset trisodium injection), a unique, injectable magnetic resonance angiography (MRA) blood pool imaging agent.
Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced that it has entered into an exclusive worldwide license agreement for a novel source of primary human cells that secrete a factor capable of inhibiting tumor cell growth and causing tumor cell death.
Twenty percent of adults who have tonsillectomies will have a complication, which is significantly higher than previously shown, according to a team of researchers. The team also found that these complications substantially increase health care expenditures.
› Verified 6 days ago
Ambler Extended Care Center Location: 32 South Bethlehem Pike, Ambler, Pennsylvania 19002 Phone: (215) 646-7050 | |
Artman Lutheran Home Location: 250 North Bethlehem Pike, Ambler, Pennsylvania 19002 Phone: (215) 643-6333 |